Generalisability of pharmaceutical RCT eligibility criteria for PPF

As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Associate Editor Yet Khor about the generalisability of pharmaceutical randomised controlled trial (RCT) eligibility criteria for progressive pulmonary fibrosis (PPF).

 

Download

Listen on SoundCloud

Listen on Spotify

Listen on Apple Podcasts

Recent episodes

Watch previous episodes

Load more